Two Gene Therapy Players Launch IPOs on Stormy Stock Market

Two Gene Therapy Players Launch IPOs on Stormy Stock Market
Two Gene Therapy Players Launch IPOs on Stormy Stock Market
Two Gene Therapy Players Launch IPOs on Stormy Stock Market

After a drought of more than a year, the European gene therapy sector saw initial public offerings from Genenta Science and Genflow Biosciences.